Uncategorised - European Medical Journal

Effectiveness of Reducing Loneliness and Isolation with Digital Tools

Loneliness and social isolation are increasingly recognized as major public health issues, with significant impacts on both physical and mental health.

COVID-19 Testing and Vaccination Coverage Among US Refugees, 2020–2022

Between November 2020 and June 2022, the United States conducted predeparture COVID-19 testing for nearly 24,000 refugees.

Emotional Distress Impacts Melanoma Response to Immunotherapy

Results demonstrated a clear association between elevated emotional distress and poorer TIL therapy outcomes.

Impact of LMNA Variant Location on Cardiac Outcomes in Cardiomyopathy

Discover how LMNA gene variant type and position impact cardiomyopathy risk—keep reading for clinical implications and treatment guidance.

Inflammation Drives Chemoresistance in Bladder Cancer

Discover a study revealing how chemotherapy-induced tumour pyroptosis reprograms fibroblasts, promoting chemoresistance in bladder cancer.

Increased Demyelination Risk in Biologic Therapy for Rheumatic Diseases

A concerning increase in the incidence of central nervous system (CNS) demyelination among patients undergoing biologic treatments for rheumatologic diseases has been revealed by a new study.

App-Based Asthma Programme Improves Symptoms in Adults

A mobile asthma self-management tool improved symptoms in adults with uncontrolled asthma, but its effectiveness varied across racial groups.

JAK Inhibitors for Atopic Dermatitis: Does Weight Affect Outcomes?

A recent nationwide study conducted in Italy provides important insights into how body weight may influence the efficacy of JAK inhibitors in treating moderate-to-severe atopic dermatitis (AD).

Does Acupuncture Improve Postconcussion Symptoms After Mild Traumatic Brain Injury?

Learn how acupuncture offers long-term relief for postconcussion symptoms in mild traumatic brain injury.

Illustrated handshake

BMS appoints new EVP, CMO and Head of Development

Bristol Myers Squibb announces the appointment of Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of Development.